companydata.dkcompanydata.dk

DECHRA VETERINARY PRODUCTS A/S: Financial statements 2023

CVR: 10114241

Source: annual report 2023, Danish Business Authority

01/07/2022 – 30/06/2023

DECHRA VETERINARY PRODUCTS A/S (CVR 10114241) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 2,513,140,000 and a net result of DKK 129,704,000 compared with DKK 157,581,000 the year before. That is an increase of 6.1% compared with the year before. The profit margin was 5.2%. Equity in the 2023 report amounted to DKK 688,900,000. The solvency ratio was 50.8%. The company had 110 employees in the financial year.

Revenue
DKK 2,513,140,000
Gross Profit
DKK 238,874,000
Profit/Loss
DKK 129,704,000
Equity
DKK 688,900,000
Total Assets
DKK 1,356,395,000
Employees
110

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20232.5B238.9M129.7M688.9M110
20222.4B255.8M157.6M560.4M108
20212.1B192.2M98.3M403.1M98
20201.6B112M23.3M302.8M91
20191.4B193.6M96.5M555.8M76

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Paul Nicholas Sandland joins the board of DECHRA VETERINARY PRODUCTS A/SNov 27, 2023

As of November 27, 2023, Paul Nicholas Sandland has joined the board of directors of DECHRA VETERINARY PRODUCTS A/S.

Anthony Gerard Griffin leaves the board of DECHRA VETERINARY PRODUCTS A/SNov 27, 2023

As of November 27, 2023, Anthony Gerard Griffin has left the board of directors of DECHRA VETERINARY PRODUCTS A/S.

About DECHRA VETERINARY PRODUCTS A/S

DECHRA VETERINARY PRODUCTS A/S is a Danish company of the type Aktieselskab based in Uldum, founded in 1986. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named VETXX A/S and LEO ANIMAL HEALTH A/S. The management consists of Ian Machan Mackellar. The board consists of Ajay Gandhi (chair), Ian Machan Mackellar and Robert Mark Leather. The company is owned by Dechra Pharmaceuticals Limited. The company has 122 employees (2026). In 2025, the company reported revenue of DKK 2,875,016,000 and a net result of DKK 189,967,000 compared with DKK 116,939,000 the year before. Equity in the 2025 report amounted to DKK 571,636,000.

Source: annual report 2025, Danish Business Authority